Improving recombinant protein productivity in CHO cells via multi-omics data integration

Abstract

Chinese hamster ovary (CHO) cells represent the dominant host system for the production of recombinant therapeutic proteins. In recent decades, extensive research has focused on process/media optimization and cell line engineering to improve both the productivity and quality of biopharmaceutical proteins produced in CHO cells. Nevertheless, the inherent complexity of biological pathways and the heterogeneous cellular responses to different environmental conditions have posed substantial challenges to traditional methodologies. Recent advances in omics technologies have enabled comprehensive characterization of CHO cell physiology, providing multidimensional molecular and phenotypic insights that facilitate the enhancement of recombinant protein production. This review first summarizes the methodologies and advances in CHO omics research, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. It then examines contemporary approaches to integrate and analyze multi-omics data in CHO cells. The review further elucidates how these multi-omics datasets can be strategically applied across various developmental stages, including cell line selection, genetic engineering, expression vector design, and bioprocess optimization. Finally, we explore the transformative potential of integrating multi-omics with artificial intelligence and discuss promising future research directions in CHO cell studies. These emerging paradigms offer novel opportunities for data-driven cell engineering and bioprocess optimization in CHO-based biomanufacturing.

Graphical abstract

Keywords

CHO cells / Bioprocessing / Omics / Cell engineering / Process optimization

References

[1] Agarwal P, McCready C, Ng SK, Ng JC, van de Laar J, et al.. Hybrid modeling for in silico optimization of a dynamic perfusion cell culture process. Biotechnol Prog, 2025, 41(1e3503

[2] Ahn WS, Antoniewicz MR. Metabolic flux analysis of CHO cells at growth and non-growth phases using isotopic tracers and mass spectrometry. Metab Eng, 2011, 13(5): 598-609

[3] Albrecht S, Kaisermayer C, Gallagher C, Farrell A, Lindeberg A, et al.. Proteomics in biomanufacturing control: protein dynamics of CHO-K1 cells and conditioned media during apoptosis and necrosis. Biotechnol Bioeng, 2018, 115(6): 1509-1520

[4] Alden N, Raju R, McElearney K, Lambropoulos Jl, Kshirsagar R, et al.. Using Metabolomics to Identify cell line-independent indicators of growth inhibition for Chinese hamster ovary cell-based bioprocesses. Metabolites, 2020

[5] Ali AS, Raju R, Kshirsagar R, Ivanov AR, Gilbert A, et al.. Multi-omics study on the impact of cysteine feed level on cell viability and mAb production in a CHO bioprocess. Biotechnol J, 2019, 14(4): e1800352

[6] Ali AS, Chen R, Raju R, Kshirsagar R, Gilbert A, et al.. Multi-omics reveals impact of cysteine feed concentration and resulting redox imbalance on cellular energy metabolism and specific productivity in CHO cell bioprocessing. Biotechnol J, 2020, 15(8): e1900565

[7] Alsayyari AA, Pan X, Dalm C, van der Veen JW, Vriezen N, et al.. Transcriptome analysis for the scale-down of a CHO cell fed-batch process. J Biotechnol, 2018, 279: 61-72

[8] Bai Y, Mercade ID, Elgendy R, Lambiase G, Peak-Chew S, et al.. Identification of cellular signatures associated with chinese hamster ovary cell adaptation for secretion of antibodies. Comput Struct Biotechnol J, 2025, 27: 17-31

[9] Baik JY, Lee GM. A DIGE approach for the assessment of differential expression of the CHO proteome under sodium butyrate addition: effect of Bcl-x(L) overexpression. Biotechnol Bioeng, 2010, 105(2): 358-367

[10] Baik JY, Lee MS, An SR, Yoon SK, Joo EJ, et al.. Initial transcriptome and proteome analyses of low culture temperature-induced expression in CHO cells producing erythropoietin. Biotechnol Bioeng, 2006, 93(2): 361-371

[11] Barberi G, Benedetti A, Diaz-Fernandez P, Sevin DC, Vappiani J, et al.. Integrating metabolome dynamics and process data to guide cell line selection in biopharmaceutical process development. Metab Eng, 2022, 72: 353-364

[12] Baycin-Hizal D, Tabb DL, Chaerkady R, Chen L, Lewis NE, et al.. Proteomic analysis of Chinese hamster ovary cells. J Proteome Res, 2012, 11(11): 5265-5276

[13] Bersanelli M, Mosca E, Remondini D, Giampieri E, Sala C, et al.. Methods for the integration of multi-omics data: mathematical aspects. BMC Bioinf 17 Suppl, 2016, 2(Suppl 2): 15

[14] Bing X, Lovelace T, Bunea F, Wegkamp M, Kasturi SP, et al.. Essential regression: a generalizable framework for inferring causal latent factors from multi-omic datasets. Patterns (N Y), 2022, 3(5): 100473

[15] Birzele F, Schaub J, Rust W, Clemens C, Baum P, et al.. Into the unknown: expression profiling without genome sequence information in CHO by next generation sequencing. Nucleic Acids Res, 2010, 38(12): 3999-4010

[16] Blondeel EJM, Ho R, Schulze S, Sokolenko S, Guillemette SR, et al.. An omics approach to rational feed: enhancing growth in CHO cultures with NMR metabolomics and 2D-DIGE proteomics. J Biotechnol, 2016, 234: 127-138

[17] Borsi G, Motheramgari K, Dhiman H, Baumann M, Sinkala E, et al.. Single-cell RNA sequencing reveals homogeneous transcriptome patterns and low variance in a suspension CHO-K1 and an adherent HEK293FT cell line in culture conditions. J Biotechnol, 2023, 364: 13-22

[18] Brinkrolf K, Rupp O, Laux H, Kollin F, Ernst W, et al.. Chinese hamster genome sequenced from sorted chromosomes. Nat Biotechnol, 2013, 31(8): 694-695

[19] Brown AJ, Gibson SJ, Hatton D, James DC. In silico design of context-responsive mammalian promoters with user-defined functionality. Nucleic Acids Res, 2017, 45(18): 10906-10919

[20] Bryan L, Henry M, Kelly RM, Frye CC, Osborne MD, et al.. Mapping the molecular basis for growth related phenotypes in industrial producer CHO cell lines using differential proteomic analysis. BMC Biotechnol, 2021, 21(1): 43

[21] Bryan L, Henry M, Kelly RM, Lloyd M, Frye CC, et al.. Global phosphoproteomic study of high/low specific productivity industrially relevant mAb producing recombinant CHO cell lines. Curr Res Biotechnol, 2021, 3: 49-56

[22] Buchsteiner M, Quek LE, Gray P, Nielsen LK. Improving culture performance and antibody production in CHO cell culture processes by reducing the Warburg effect. Biotechnol Bioeng, 2018, 115(9): 2315-2327

[23] Busch DJ, Zhang Y, Kumar A, Huhn SC, Du Z, et al.. Identification of RNA content of CHO-derived extracellular vesicles from a production process. J Biotechnol, 2022, 348: 36-46

[24] Calmels C, McCann A, Malphettes L, Andersen MR. Application of a curated genome-scale metabolic model of CHO DG44 to an industrial fed-batch process. Metab Eng, 2019, 51: 9-19

[25] Cao J, Novoa EM, Zhang Z, Chen WCW, Liu D, et al.. High-throughput 5’ UTR engineering for enhanced protein production in non-viral gene therapies. Nat Commun, 2021, 12(1): 4138

[26] Capella Roca B, Doolan P, Barron N, O’Neill F, Clynes M. Altered gene expression in CHO cells following polyamine starvation. Biotechnol Lett, 2020, 42(6): 927-936

[27] Carlage T, Kshirsagar R, Zang L, Janakiraman V, Hincapie M, et al.. Analysis of dynamic changes in the proteome of a Bcl-XL overexpressing Chinese hamster ovary cell culture during exponential and stationary phases. Biotechnol Prog, 2012, 28(3): 814-823

[28] Chang M, Huhn S, Nelson L, Betenbaugh M, Du Z. Significant impact of mTORC1 and ATF4 pathways in CHO cell recombinant protein production induced by CDK4/6 inhibitor. Biotechnol Bioeng, 2022, 119(5): 1189-1206

[29] Chang M, Kumar A, Kumar S, Huhn S, Timp W, et al.. Epigenetic comparison of CHO hosts and clones reveals divergent methylation and transcription patterns across lineages. Biotechnol Bioeng, 2022, 119(4): 1062-1076

[30] Chen C, Le H, Goudar CT. An automated RNA-Seq analysis pipeline to identify and visualize differentially expressed genes and pathways in CHO cells. Biotechnol Prog, 2015, 31(5): 1150-1162

[31] Cheng JK, Alper HS. Transcriptomics-guided design of synthetic promoters for a Mammalian system. ACS Synth Biol, 2016, 5(12): 1455-1465

[32] Chevallier V, Schoof EM, Malphettes L, Andersen MR, Workman CT. Characterization of glutathione proteome in CHO cells and its relationship with productivity and cholesterol synthesis. Biotechnol Bioeng, 2020, 117(11): 3448-3458

[33] Chong WP, Reddy SG, Yusufi FN, Lee DY, Wong NS, et al.. Metabolomics-driven approach for the improvement of Chinese hamster ovary cell growth: overexpression of malate dehydrogenase II. J Biotechnol, 2010, 147(2): 116-121

[34] Chong WP, Yusufi FN, Lee DY, Reddy SG, Wong NS, et al.. Metabolomics-based identification of apoptosis-inducing metabolites in recombinant fed-batch CHO culture media. J Biotechnol, 2011, 151(2): 218-224

[35] Chong WP, Thng SH, Hiu AP, Lee DY, Chan EC, et al.. LC-MS-based metabolic characterization of high monoclonal antibody-producing Chinese hamster ovary cells. Biotechnol Bioeng, 2012, 109(12): 3103-3111

[36] Clappier C, Bottner D, Heinzelmann D, Stadermann A, Schulz P, et al.. Deciphering integration loci of CHO manufacturing cell lines using long read nanopore sequencing. N Biotechnol, 2023, 75: 31-39

[37] Clarke C, Doolan P, Barron N, Meleady P, O’Sullivan F, et al.. Large scale microarray profiling and coexpression network analysis of CHO cells identifies transcriptional modules associated with growth and productivity. J Biotechnol, 2011, 155(3): 350-359

[38] Combe M, Sokolenko S. Quantifying the impact of cell culture media on CHO cell growth and protein production. Biotechnol Adv, 2021, 50: 107761

[39] Corredor C, Zhao Y, Wu S, Drennen JK, Anderson C. Novel Approach Using Real-Time Dynamic Imaging Analysis to Monitor Cellular Apoptosis, Viability, and Cell Density in CHO Cell-Based Bioprocesses for Monoclonal Antibody Production. Biotechnol J, 2025, 20(4): e70018

[40] Costello A, Coleman O, Lao NT, Henry M, Meleady P, et al.. Depletion of endogenous miRNA-378-3p increases peak cell density of CHO DP12 cells and is correlated with elevated levels of ubiquitin carboxyl-terminal hydrolase 14. J Biotechnol, 2018, 288: 30-40

[41] Coulet M, Kepp O, Kroemer G, Basmaciogullari S (2022) Metabolic Profiling of CHO Cells during the Production of Biotherapeutics. Cells 11(12). https://doi.org/10.3390/cells11121929

[42] Dahodwala H, Sharfstein ST. The ‘Omics Revolution in CHO Biology: Roadmap to Improved CHO Productivity. Methods Mol Biol, 2025, 2853: 119-137

[43] Dahodwala H, Kaushik P, Tejwani V, Kuo CC, Menard P, et al.. Increased mAb production in amplified CHO cell lines is associated with increased interaction of CREB1 with transgene promoter. Curr Res Biotechnol, 2019, 1: 49-57

[44] de la Torre BG, Albericio F (2024) The pharmaceutical industry in 2023: An analysis of FDA drug approvals from the perspective of molecules. Molecules 29(3). https://doi.org/10.3390/molecules29030585

[45] de Vree PJ, de Wit E, Yilmaz M, van de Heijning M, Klous P, et al.. Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nat Biotechnol, 2014, 32(10): 1019-1025

[46] Dean J, Reddy P. Metabolic analysis of antibody producing CHO cells in fed-batch production. Biotechnol Bioeng, 2013, 110(6): 1735-1747

[47] Desmurget C, Perilleux A, Souquet J, Borth N, Douet J. Molecular biomarkers identification and applications in CHO bioprocessing. J Biotechnol, 2024, 392: 11-24

[48] Dhara VG, Kumar S, DeVine L, Naik HM, Cole RN, et al.. Cottonseed hydrolysate supplementation alters metabolic and proteomics responses in Chinese hamster ovary cell cultures. Biotechnol J, 2023, 18(6): e2200243

[49] Dhiman H, Gerstl MP, Ruckerbauer D, Hanscho M, Himmelbauer H, et al.. Genetic and epigenetic variation across genes involved in energy metabolism and mitochondria of Chinese hamster ovary cell lines. Biotechnol J, 2019, 14(7): e1800681

[50] Dhiman H, Campbell M, Melcher M, Smith KD, Borth N. Predicting favorable landing pads for targeted integrations in Chinese hamster ovary cell lines by learning stability characteristics from random transgene integrations. Comput Struct Biotechnol J, 2020, 18: 3632-3648

[51] Di Giusto P, Choi DH, Antonakoudis A, Duraikannan VG, Craveur P, et al.. A community reconstruction of Chinese hamster metabolism and structural systems biology elucidate metabolic rewiring in lactate-free CHO cells. Cell Syst, 2026, 17(6): 101574

[52] Dietmair S, Hodson MP, Quek LE, Timmins NE, Chrysanthopoulos P, et al.. Metabolite profiling of CHO cells with different growth characteristics. Biotechnol Bioeng, 2012, 109(6): 1404-1414

[53] Donaldson J, Kleinjan DJ, Rosser S. Synthetic biology approaches for dynamic CHO cell engineering. Curr Opin Biotechnol, 2022, 78: 102806

[54] Eberwine J, Kim J, Anafi RC, Brem S, Bucan M, et al.. Subcellular omics: a new frontier pushing the limits of resolution, complexity and throughput. Nat Methods, 2023, 20(3): 331-335

[55] Farrell A, McLoughlin N, Milne JJ, Marison IW, Bones J. Application of multi-omics techniques for bioprocess design and optimization in Chinese hamster ovary cells. J Proteome Res, 2014, 13(7): 3144-3159

[56] Feichtinger J, Hernandez I, Fischer C, Hanscho M, Auer N, et al.. Comprehensive genome and epigenome characterization of CHO cells in response to evolutionary pressures and over time. Biotechnol Bioeng, 2016, 113(10): 2241-2253

[57] Fischer S, Handrick R, Otte K. The art of CHO cell engineering: a comprehensive retrospect and future perspectives. Biotechnol Adv, 2015, 33(8): 1878-1896

[58] Fomina-Yadlin D, Mujacic M, Maggiora K, Quesnell G, Saleem R, et al.. Transcriptome analysis of a CHO cell line expressing a recombinant therapeutic protein treated with inducers of protein expression. J Biotechnol, 2015, 212: 106-115

[59] Fouladiha H, Marashi SA, Li S, Li Z, Masson HO, et al.. Systematically gap-filling the genome-scale metabolic model of CHO cells. Biotechnol Lett, 2021, 43(1): 73-87

[60] Gam JJ, Chang MM, Zheng D, Stevens J, Nielsen AAK, et al.. Optimizing bispecific antibody expression via multi-omics analysis and vector redesign. Biotechnol Bioeng, 2026, 123(7): 1942-1950

[61] Gansemer ER, McCommis KS, Martino M, King-McAlpin AQ, Potthoff MJ, et al.. NADPH and glutathione redox link TCA cycle activity to endoplasmic reticulum homeostasis. iScience, 2020, 23(5): 101116

[62] Gao Y, Ray S, Dai S, Ivanov AR, Abu-Absi NR, et al.. Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess. Biotechnol J, 2016, 11(9): 1190-1200

[63] Gerstl MP, Hanscho M, Ruckerbauer DE, Zanghellini J, Borth N (2017) CHOmine: an integrated data warehouse for CHO systems biology and modeling. Database (Oxford) 2017. https://doi.org/10.1093/database/bax034

[64] Gopalakrishnan S, Joshi CJ, Valderrama-Gomez MA, Icten E, Rolandi P, et al.. Guidelines for extracting biologically relevant context-specific metabolic models using gene expression data. Metab Eng, 2023, 75: 181-191

[65] Gopalakrishnan S, Johnson W, Valderrama-Gomez MA, Icten E, Tat J, et al.. Multi-omic characterization of antibody-producing CHO cell lines elucidates metabolic reprogramming and nutrient uptake bottlenecks. Metab Eng, 2024, 85: 94-104

[66] Gowtham YK, Saski CA, Harcum SW. Low glucose concentrations within typical industrial operating conditions have minimal effect on the transcriptome of recombinant CHO cells. Biotechnol Prog, 2017, 33(3): 771-785

[67] Grassi L, Harris C, Zhu J, Hatton D, Dunn S. Next-generation sequencing: a powerful multi-purpose tool in cell line development for biologics production. Comput Struct Biotechnol J, 2025, 27: 1511-1517

[68] Greenfield L, Brantley M, Geoffroy P, Mitchell J, DeWitt D, et al.. Metabolic engineering of CHO cells towards cysteine prototrophy and systems analysis of the ensuing phenotype. Metab Eng, 2024, 84: 128-144

[69] Grilo AL, Mantalaris A. Apoptosis: a mammalian cell bioprocessing perspective. Biotechnol Adv, 2019, 37(3): 459-475

[70] Groot J, Zhou Y, Marshall E, Cullen P, Carlile T, et al.. Benchmarking and optimization of a high-throughput sequencing based method for transgene sequence variant analysis in biotherapeutic cell line development. Biotechnol J, 2021, 16(8): e2000548

[71] Guo X, Wang C, Wang TY. Chromatin-modifying elements for recombinant protein production in mammalian cell systems. Crit Rev Biotechnol, 2020, 40(7): 1035-1043

[72] Gurazada SGR (2024) Machine learning-driven multi-omics for optimizing biotherapeutic production. Ph.D. Dissertation. Center for bioinformatics and computational biology, University of Delaware

[73] Gutierrez JM, Feizi A, Li S, Kallehauge TB, Hefzi H, et al.. Genome-scale reconstructions of the mammalian secretory pathway predict metabolic costs and limitations of protein secretion. Nat Commun, 2020, 11(1): 68

[74] Hackl M, Jakobi T, Blom J, Doppmeier D, Brinkrolf K, et al.. Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering. J Biotechnol, 2011, 153(1–2): 62-75

[75] Harreither E, Hackl M, Pichler J, Shridhar S, Auer N, et al.. Microarray profiling of preselected CHO host cell subclones identifies gene expression patterns associated with increased production capacity. Biotechnol J, 2015, 10(10): 1625-1638

[76] Heffner K, Hizal DB, Majewska NI, Kumar S, Dhara VG, et al.. Expanded Chinese hamster organ and cell line proteomics profiling reveals tissue-specific functionalities. Sci Rep, 2020, 10(1): 15841

[77] Heffner KM, Wang Q, Hizal DB, Can O, Betenbaugh MJ. Glycoengineering of mammalian expression systems on a cellular level. Adv Biochem Eng Biotechnol, 2021, 175: 37-69

[78] Hefzi H, Ang KS, Hanscho M, Bordbar A, Ruckerbauer D, et al.. A consensus genome-scale reconstruction of Chinese hamster ovary cell metabolism. Cell Syst, 2016, 3(5): 434-443e8

[79] Henry M, Power M, Kaushik P, Coleman O, Clynes M, et al.. Differential phosphoproteomic analysis of recombinant Chinese hamster ovary cells following temperature shift. J Proteome Res, 2017, 16(7): 2339-2358

[80] Hernandez I, Dhiman H, Klanert G, Jadhav V, Auer N, et al.. Epigenetic regulation of gene expression in Chinese hamster ovary cells in response to the changing environment of a batch culture. Biotechnol Bioeng, 2019, 116(3): 677-692

[81] Hernandez Bort JA, Hackl M, Hoflmayer H, Jadhav V, Harreither E, et al.. Dynamic mRNA and miRNA profiling of CHO-K1 suspension cell cultures. Biotechnol J, 2012, 7(4): 500-515

[82] Hertel O, Neuss A, Busche T, Brandt D, Kalinowski J, et al.. Enhancing stability of recombinant CHO cells by CRISPR/Cas9-mediated site-specific integration into regions with distinct histone modifications. Front Bioeng Biotechnol, 2022, 10: 1010719

[83] Hilliard W, Lee KH. Systematic identification of safe harbor regions in the CHO genome through a comprehensive epigenome analysis. Biotechnol Bioeng, 2021, 118(2): 659-675

[84] Hilliard W, Lee KH. A compendium of stable hotspots in the CHO genome. Biotechnol Bioeng, 2023, 120(8): 2133-2143

[85] Hilliard W, MacDonald ML, Lee KH. Chromosome-scale scaffolds for the Chinese hamster reference genome assembly to facilitate the study of the CHO epigenome. Biotechnol Bioeng, 2020, 117(8): 2331-2339

[86] Hsu HH, Araki M, Mochizuki M, Hori Y, Murata M, et al.. A systematic approach to time-series metabolite profiling and RNA-seq analysis of Chinese hamster ovary cell culture. Sci Rep, 2017, 7: 43518

[87] Jamnikar U, Nikolic P, Belic A, Blas M, Gaser D, et al.. Transcriptome study and identification of potential marker genes related to the stable expression of recombinant proteins in CHO clones. BMC Biotechnol, 2015, 15: 98

[88] Jerabek T, Keysberg C, Otte K. The potential of emerging sub-omics technologies for CHO cell engineering. Biotechnol Adv, 2022, 59: 107978

[89] Jerabek T, Klingler F, Raab N, Zeh N, Pfannstiel J, et al.. Life at the periphery: what makes CHO cells survival talents. Appl Microbiol Biotechnol, 2022, 106(18): 6157-6167

[90] Jia YL, Guo X, Ni TJ, Lu JT, Wang XY, et al.. Novel short synthetic matrix attachment region for enhancing transgenic expression in recombinant Chinese hamster ovary cells. J Cell Biochem, 2019, 120(10): 18478-18486

[91] Jiang W, Ye W, Tan X, Bao YJ. Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BioData Min, 2025, 18(1): 27

[92] Johari YB, Brown AJ, Alves CS, Zhou Y, Wright CM, et al.. CHO genome mining for synthetic promoter design. J Biotechnol, 2019, 294: 1-13

[93] Josse L, Zhang L, Smales CM. Application of microRNA targeted 3’UTRs to repress DHFR selection marker expression for development of recombinant antibody expressing CHO cell pools. Biotechnol J, 2018, 13(10): e1800129

[94] Kaas CS, Kristensen C, Betenbaugh MJ, Andersen MR. Sequencing the CHO DXB11 genome reveals regional variations in genomic stability and haploidy. BMC Genomics, 2015, 16(1): 160

[95] Kalkan AK, Palaz F, Sofija S, Elmousa N, Ledezma Y, et al.. Improving recombinant protein production in CHO cells using the CRISPR-Cas system. Biotechnol Adv, 2023, 64: 108115

[96] Kang S, Ren D, Xiao G, Daris K, Buck L, et al.. Cell line profiling to improve monoclonal antibody production. Biotechnol Bioeng, 2014, 111(4): 748-760

[97] Kantardjieff A, Jacob NM, Yee JC, Epstein E, Kok YJ, et al.. Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment. J Biotechnol, 2010, 145(2): 143-159

[98] Karst DJ, Steinhoff RF, Kopp MRG, Serra E, Soos M, et al.. Intracellular CHO cell metabolite profiling reveals steady-state dependent metabolic fingerprints in perfusion culture. Biotechnol Prog, 2017, 33(4): 879-890

[99] Kaushik P, Henry M, Clynes M, Meleady P. The expression pattern of the phosphoproteome is significantly changed during the growth phases of recombinant CHO cell culture. Biotechnol J, 2018, 13(10): e1700221

[100] Keysberg C, Hertel O, Schelletter L, Busche T, Sochart C, et al.. Exploring the molecular content of CHO exosomes during bioprocessing. Appl Microbiol Biotechnol, 2021, 105(9): 3673-3689

[101] Kim JY, Kim YG, Han YK, Choi HS, Kim YH, et al.. Proteomic understanding of intracellular responses of recombinant Chinese hamster ovary cells cultivated in serum-free medium supplemented with hydrolysates. Appl Microbiol Biotechnol, 2011, 89(6): 1917-1928

[102] Kim M, O’Callaghan PM, Droms KA, James DC. A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies. Biotechnol Bioeng, 2011, 108(10): 2434-2446

[103] Kinch MS. An overview of FDA-approved biologics medicines. Drug Discov Today, 2015, 20(4): 393-398

[104] Kirshina A, Vasileva O, Kunyk D, Seregina K, Muslimov A. Effects of combinations of untranslated-region sequences on translation of mRNA. Biomolecules, 2023

[105] Klingler F, Mathias S, Schneider H, Buck T, Raab N, et al.. Unveiling the CHO surfaceome: identification of cell surface proteins reveals cell aggregation-relevant mechanisms. Biotechnol Bioeng, 2021, 118(8): 3015-3028

[106] Konitzer JD, Muller MM, Leparc G, Pauers M, Bechmann J, et al.. A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation. Biotechnol J, 2015, 10(9): 1412-1423

[107] Kotidis P, Donini R, Arnsdorf J, Hansen AH, Voldborg BGR, et al.. CHOGlycoNET: comprehensive glycosylation reaction network for CHO cells. Metab Eng, 2023, 76: 87-96

[108] Kremkow BG, Baik JY, MacDonald ML, Lee KH. CHOgenome.org 2.0: genome resources and website updates. Biotechnol J, 2015, 10(7): 931-938

[109] Kretz R, Walter L, Raab N, Zeh N, Gauges R, et al.. Spatial proteomics reveals differences in the cellular architecture of antibody-producing CHO and Plasma cell-derived cells. Mol Cell Proteom, 2022, 21(10): 100278

[110] Kumar N, Gammell P, Meleady P, Henry M, Clynes M. Differential protein expression following low temperature culture of suspension CHO-K1 cells. BMC Biotechnol, 2008, 8: 42

[111] Kumar A, Baycin-Hizal D, Wolozny D, Pedersen LE, Lewis NE, et al.. Elucidation of the CHO Super-Ome (CHO-SO) by proteoinformatics. J Proteome Res, 2015, 14(11): 4687-4703

[112] Kumar S, Dhara VG, Orzolek LD, Hao H, More AJ, et al.. Elucidating the impact of cottonseed hydrolysates on CHO cell culture performance through transcriptomic analysis. Appl Microbiol Biotechnol, 2021, 105(1): 271-285

[113] Kumar S, Kumar A, Huhn S, DeVine L, Cole R, et al.. A proteomics approach to decipher a sticky CHO situation. Biotechnol Bioeng, 2022, 119(8): 2064-2075

[114] Kuystermans D, Dunn MJ, Al-Rubeai M. A proteomic study of cMyc improvement of CHO culture. BMC Biotechnol, 2010, 10: 25

[115] Lakshmanan M, Kok YJ, Lee AP, Kyriakopoulos S, Lim HL, et al.. Multi-omics profiling of CHO parental hosts reveals cell line-specific variations in bioprocessing traits. Biotechnol Bioeng, 2019, 116(9): 2117-2129

[116] Lee KH, Sburlati A, Renner WA, Bailey JE. Deregulated expression of cloned transcription factor E2F-1 in Chinese hamster ovary cells shifts protein patterns and activates growth in protein-free medium. Biotechnol Bioeng, 1996, 50(3): 273-279

[117] Lee AP, Kok YJ, Lakshmanan M, Leong D, Zheng L, et al.. Multi-omics profiling of a CHO cell culture system unravels the effect of culture pH on cell growth, antibody titer, and product quality. Biotechnol Bioeng, 2021, 118(11): 4305-4316

[118] Lee M, Han SH, Kim D, Yun S, Yeom J, et al.. Systematic identification of genomic hotspots for high-yield protein production in CHO cells. N Biotechnol, 2025, 88: 61-72

[119] Leppek K, Byeon GW, Kladwang W, Wayment-Steele HK, Kerr CH, et al.. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat Commun, 2022, 13(1): 1536

[120] Lewis NE, Liu X, Li Y, Nagarajan H, Yerganian G, et al.. Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. Nat Biotechnol, 2013, 31(8): 759-765

[121] Li YM, Tian ZW, Xu DH, Wang XY, Wang TY. Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells. Mol Biol Rep, 2018, 45(6): 2907-2912

[122] Li J, Miao B, Wang S, Dong W, Xu H et al (2022a) Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization. Brief Bioinform 23(4). https://doi.org/10.1093/bib/bbac261

[123] Li WF, Fan ZL, Wang XY, Lin Y, Wang TY. Combination of sodium butyrate and decitabine promotes transgene expression in CHO cells via apoptosis inhibition. N Biotechnol, 2022, 69: 8-17

[124] Li ZM, Fan ZL, Wang XY, Wang TY. Factors affecting the expression of recombinant protein and improvement strategies in Chinese hamster ovary cells. Front Bioeng Biotechnol, 2022, 10: 880155

[125] Li M, Xiao M, Wu Z. Physics-encoded transfer learning for scale-up modeling of CHO cell bioreactors. AIChE J, 2026, 2026: e70542

[126] Lin D, Yalamanchili HB, Zhang X, Lewis NE, Alves CS, et al.. CHOmics: a web-based tool for multi-omics data analysis and interactive visualization in CHO cell lines. PLoS Comput Biol, 2020, 16(12): e1008498

[127] Liu X, Chen Y, Zhao Y, Liu-Compton V, Chen W, et al.. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process. J Pharm Biomed Anal, 2019, 174: 500-508

[128] Liu HN, Dong WH, Lin Y, Zhang ZH, Wang TY. The Effect of microRNA on the production of recombinant protein in CHO cells and its mechanism. Front Bioeng Biotechnol, 2022, 10: 832065

[129] Liu T, Salguero P, Petek M, Martinez-Mira C, Balzano-Nogueira L, et al.. PaintOmics 4: new tools for the integrative analysis of multi-omics datasets supported by multiple pathway databases. Nucleic Acids Res, 2022, 50(W1): W551-W559

[130] Liu HN, Wang XY, Zou Y, Wu WB, Lin Y, et al.. Synthetic enhancers including TFREs improve transgene expression in CHO cells. Heliyon, 2024, 10(5): e26901

[131] Liu Y, Ding X, Mou L, Li X, Cai Y, et al.. Systematic screening of stable expression loci in Chinese hamster ovary cells via orthogonal functional annotation analysis. Gene, 2026, 1007: 150234

[132] Logsdon GA, Vollger MR, Eichler EE. Long-read human genome sequencing and its applications. Nat Rev Genet, 2020, 21(10): 597-614

[133] Lu JT, Xiao MK, Feng YY, Wang XY, Qiu LL, et al.. Apilimod enhances specific productivity in recombinant CHO cells through cell cycle arrest and mediation of autophagy. Biotechnol J, 2023, 18(2): e2200147

[134] Lund AM, Kaas CS, Brandl J, Pedersen LE, Kildegaard HF, et al.. Network reconstruction of the mouse secretory pathway applied on CHO cell transcriptome data. BMC Syst Biol, 2017, 11(1): 37

[135] Mahe A, Martine A, Fagete S, Girod PA. Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production. Bioprocess Biosyst Eng, 2022, 45(2): 297-307

[136] Malm M, Kuo CC, Barzadd MM, Mebrahtu A, Wistbacka N, et al.. Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins. Metab Eng, 2022, 72: 171-187

[137] Marx N, Eisenhut P, Weinguny M, Klanert G, Borth N. How to train your cell—towards controlling phenotypes by harnessing the epigenome of Chinese hamster ovary production cell lines. Biotechnol Adv, 2022, 56: 107924

[138] Masson HO, Di Giusto P, Kuo CC, Malm M, Lundqvist M, et al.. Deciphering the determinants of recombinant protein expression across the human secretome. Proc Natl Acad Sci U S A, 2025, 122(41): e2506036122

[139] Meleady P, Gallagher M, Clarke C, Henry M, Sanchez N, et al.. Impact of miR-7 over-expression on the proteome of Chinese hamster ovary cells. J Biotechnol, 2012, 160(3–4): 251-262

[140] Mishra P, Mehra S. Genome amplification and altered transcriptome aid in survival and enhanced protein secretion in tunicamycin-resistant CHOK1 cells. Biotechnol J, 2025, 20(12): e70163

[141] Mohmad-Saberi SE, Hashim YZ, Mel M, Amid A, Ahmad-Raus R, et al.. Metabolomics profiling of extracellular metabolites in CHO-K1 cells cultured in different types of growth media. Cytotechnology, 2013, 65(4): 577-586

[142] Morrissey J, Monteiro M, Betenbaugh M, Kontoravdi C (2025) Inferring the metabolic objectives of mammalian cells via inverse modeling of fluxomics and metabolomics. bioRxiv:2025.09.23.677837. https://doi.org/10.1101/2025.09.23.677837

[143] Motheramgari K, Valdes-Bango Curell R, Tzani I, Gallagher C, Castro-Rivadeneyra M, et al.. Expanding the Chinese hamster ovary cell long noncoding RNA transcriptome using RNASeq. Biotechnol Bioeng, 2020, 117(10): 3224-3231

[144] Muller B, Heinrich C, Jabs W, Kaspar-Schonefeld S, Schmidt A, et al.. Label-free protein quantification of sodium butyrate treated CHO cells by ESI-UHR-TOF-MS. J Biotechnol, 2017, 257: 87-98

[145] Mulukutla BC, Kale J, Kalomeris T, Jacobs M, Hiller GW. Identification and control of novel growth inhibitors in fed-batch cultures of Chinese hamster ovary cells. Biotechnol Bioeng, 2017, 114(8): 1779-1790

[146] Naik HM, Kumar S, Reddy JV, Gonzalez JE, McConnell BO, et al.. Chemical inhibitors of hexokinase-2 enzyme reduce lactate accumulation, alter glycosylation processing, and produce altered glycoforms in CHO cell cultures. Biotechnol Bioeng, 2023, 120(9): 2559-2577

[147] Ndahiro N, Ma E, Bertalan T, Donohue M, Kevrekidis Y, et al.. Integration of Bayesian optimization and solution thermodynamics to optimize media design for mammalian biomanufacturing. iScience, 2025, 28(8): 112944

[148] Nelson L, Veling M, Farhangdoust F, Cai X, Huhn S, et al.. Transcriptomics and cell painting analysis reveals molecular and morphological features associated with fed-batch production performance in CHO recombinant clones. Biotechnol Bioeng, 2023, 120(11): 3177-3190

[149] Nguyen M, Zimmer A. A reflection on the improvement of Chinese hamster ovary cell-based bioprocesses through advances in proteomic techniques. Biotechnol Adv, 2023, 65: 108141

[150] Nguyen LN, Baumann M, Dhiman H, Marx N, Schmieder V, et al.. Novel promoters derived from Chinese hamster ovary cells via in silico and in vitro analysis. Biotechnol J, 2019, 14(11): e1900125

[151] Nguyen M, Le Mignon M, Schnellbacher A, Wehsling M, Braun J, et al.. Mechanistic insights into the biological activity of S-Sulfocysteine in CHO cells using a multi-omics approach. Front Bioeng Biotechnol, 2023, 11: 1230422

[152] Nguyen Dang A, Mun M, Rose CM, Ahyow P, Meier A, et al.. Interaction of cell culture process parameters for modulating mAb afucosylation. Biotechnol Bioeng, 2019, 116(4): 831-845

[153] Noor Z, Ahn SB, Baker MS, Ranganathan S, Mohamedali A. Mass spectrometry-based protein identification in proteomics-a review. Brief Bioinform, 2021, 22(2): 1620-1638

[154] Novak N, Baumann M, Friss A, Cairns V, DeMaria C, et al.. LncRNA analysis of mAb producing CHO clones reveals marker and engineering potential. Metab Eng, 2023, 78: 26-40

[155] O’Neill P, Mistry RK, Brown AJ, James DC. Protein-specific signal peptides for mammalian vector engineering. ACS Synth Biol, 2023, 12(8): 2339-2352

[156] Ogata N, Nishimura A, Matsuda T, Kubota M, Omasa T. Single-cell transcriptome analyses reveal heterogeneity in suspension cultures and clonal markers of CHO-K1 cells. Biotechnol Bioeng, 2021, 118(2): 944-951

[157] Orellana CA, Marcellin E, Palfreyman RW, Munro TP, Gray PP, et al.. RNA-Seq highlights high clonal variation in monoclonal antibody producing CHO cells. Biotechnol J, 2018, 13(3): e1700231

[158] Orellana CA, Martinez VS, MacDonald MA, Henry MN, Gillard M, et al.. Omics driven discoveries of gene targets for apoptosis attenuation in CHO cells. Biotechnol Bioeng, 2021, 118(1): 481-490

[159] Osterlehner A, Simmeth S, Gopfert U. Promoter methylation and transgene copy numbers predict unstable protein production in recombinant Chinese hamster ovary cell lines. Biotechnol Bioeng, 2011, 108(11): 2670-2681

[160] Pan X, Alsayyari AA, Dalm C, Hageman JA, Wijffels RH, et al.. Transcriptome analysis of CHO cell size increase during a fed-batch process. Biotechnol J, 2019, 14(3): e1800156

[161] Papadaki S, Tournaviti S, Borth N, Grosskopf T, Popp O, et al.. Large-scale transcriptomics analysis reveals a novel stress biomarker in CHO cells producing difficult to express mAbs. Sci Rep, 2025, 15(1): 5643

[162] Paredes V, Park JS, Jeong Y, Yoon J, Baek K. Unstable expression of recombinant antibody during long-term culture of CHO cells is accompanied by histone H3 hypoacetylation. Biotechnol Lett, 2013, 35(7): 987-993

[163] Park JH, Jin JH, Lim MS, An HJ, Kim JW, et al.. Proteomic analysis of host cell protein dynamics in the culture supernatants of antibody-producing CHO cells. Sci Rep, 2017, 7: 44246

[164] Park J, Kim J, Lewy T, Rice CM, Elemento O, et al.. Spatial omics technologies at multimodal and single cell/subcellular level. Genome Biol, 2022, 23(1): 256

[165] Park SY, Choi DH, Song J, Lakshmanan M, Richelle A, et al.. Driving towards digital biomanufacturing by CHO genome-scale models. Trends Biotechnol, 2024, 42(9): 1192-1203

[166] Perez-Rodriguez S, Wulff T, Voldborg BG, Altamirano C, Trujillo-Roldan MA, et al.. Compartmentalized proteomic profiling outlines the crucial role of the classical secretory pathway during recombinant protein production in Chinese hamster ovary cells. ACS Omega, 2021, 6(19): 12439-12458

[167] Pilely K, Nielsen SB, Draborg A, Henriksen ML, Hansen SWK, et al.. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry. Biotechnol Prog, 2020, 36(4): e2983

[168] Pristovsek N, Nallapareddy S, Grav LM, Hefzi H, Lewis NE, et al.. Systematic evaluation of site-specific recombinant gene expression for programmable mammalian cell engineering. ACS Synth Biol, 2019, 8(4): 758-774

[169] Raab N, Zeh N, Kretz R, Weiss L, Stadermann A, et al.. Nature as blueprint: global phenotype engineering of CHO production cells based on a multi-omics comparison with plasma cells. Metab Eng, 2024, 83: 110-122

[170] Ranpura S, Maralingannavar V, Gheorghe AG, Ma E, Morrissey J, et al.. Wheels turning: CHO cell modeling moves into a digital biomanufacturing era: subtitle: CHO Metabolic Modeling. Comput Struct Biotechnol J, 2025, 27: 2796-2813

[171] Reis-Claro I, Silva MI, Moutinho A, Garcia BC, Pereira-Castro I, et al.. Application of the iPLUS non-coding sequence in improving biopharmaceuticals production. Front Bioeng Biotechnol, 2024, 12: 1355957

[172] Richelle A, Andersson D, Antonakoudis A, Jakobsson J, Pijeaud S et al (2025) A hybrid modeling framework for predictive digital twins of CHO cell culture. bioRxiv:2025.11.24.690194. https://doi.org/10.1101/2025.11.24.690194

[173] Rivera CM, Ren B. Mapping human epigenomes. Cell, 2013, 155(1): 39-55

[174] Rives D, Peak C, Blenner MA. RNASeq highlights ATF6 pathway regulators for CHO cell engineering with different impacts of ATF6beta and WFS1 knockdown on fed-batch production of IgG(1). Sci Rep, 2024, 14(1): 14141

[175] Romanova N, Noll T. Engineered and natural promoters and chromatin-modifying elements for recombinant protein expression in CHO cells. Biotechnol J, 2018, 13(3): e1700232

[176] Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell, 2017, 169(7): 1187-1200

[177] Rubini M, Berger A, Saillard T, Cantais F, Soucé M, et al.. Monitoring of monoclonal antibody critical quality attributes and free amino acids in CHO bioprocesses using Raman spectroscopy and DUPLEX-based PLS modeling. Microchem J, 2025, 218: 115583

[178] Rupp O, MacDonald ML, Li S, Dhiman H, Polson S, et al.. A reference genome of the Chinese hamster based on a hybrid assembly strategy. Biotechnol Bioeng, 2018, 115(8): 2087-2100

[179] Saldanha M, Padhye K, Warke VG, Dandekar P, Jain R. A feed enrichment strategy targeting the tricarboxylic acid cycle for increasing monoclonal antibody production and alleviating ammonia accumulation in Chinese hamster ovary cell culture. Biochem Eng J, 2023, 192: 108836

[180] Samoudi M, Masson HO, Kuo CC, Robinson CM, Lewis NE. From omics to cellular mechanisms in mammalian cell factory development. Curr Opin Chem Eng, 2021

[181] Schelletter L, Albaum S, Walter S, Noll T, Hoffrogge R. Clonal variations in CHO IGF signaling investigated by SILAC-based phosphoproteomics and LFQ-MS. Appl Microbiol Biotechnol, 2019, 103(19): 8127-8143

[182] Schraivogel D, Gschwind AR, Milbank JH, Leonce DR, Jakob P, et al.. Targeted Perturb-seq enables genome-scale genetic screens in single cells. Nat Methods, 2020, 17(6): 629-635

[183] Schulz A, Munro T, Puklowski A, Slack E, Tolstrup AB, et al.. Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production. MAbs, 2026, 18(1): 2615475

[184] Schulze M, Kumar Y, Rattay M, Niemann J, Wijffels RH, et al.. Transcriptomic analysis reveals mode of action of butyric acid supplementation in an intensified CHO cell fed-batch process. Biotechnol Bioeng, 2022, 119(9): 2359-2373

[185] Sellick CA, Croxford AS, Maqsood AR, Stephens GM, Westerhoff HV, et al.. Metabolite profiling of CHO cells: molecular reflections of bioprocessing effectiveness. Biotechnol J, 2015, 10(9): 1434-1445

[186] Selvarasu S, Ho YS, Chong WP, Wong NS, Yusufi FN, et al.. Combined in silico modeling and metabolomics analysis to characterize fed-batch CHO cell culture. Biotechnol Bioeng, 2012, 109(6): 1415-1429

[187] Sengupta N, Rose ST, Morgan JA. Metabolic flux analysis of CHO cell metabolism in the late non-growth phase. Biotechnol Bioeng, 2011, 108(1): 82-92

[188] Shen D, Kiehl TR, Khattak SF, Li ZJ, He A, et al.. Transcriptomic responses to sodium chloride-induced osmotic stress: a study of industrial fed-batch CHO cell cultures. Biotechnol Prog, 2010, 26(4): 1104-1115

[189] Shin SW, Kim SH, Gasselin A, Lee GM, Lee JS. Comprehensive genome-scale CRISPR knockout screening of CHO cells. Sci Data, 2025, 12(1): 71

[190] Shridhar S, Klanert G, Auer N, Hernandez-Lopez I, Kandula MM, et al.. Transcriptomic changes in CHO cells after adaptation to suspension growth in protein-free medium analysed by a species-specific microarray. J Biotechnol, 2017, 257: 13-21

[191] Sieck JB, Budach WE, Suemeghy Z, Leist C, Villiger TK, et al.. Adaptation for survival: phenotype and transcriptome response of CHO cells to elevated stress induced by agitation and sparging. J Biotechnol, 2014, 189: 94-103

[192] Sim KH, Liu LC, Tan HT, Tan K, Ng D, et al.. A comprehensive CHO SWATH-MS spectral library for robust quantitative profiling of 10,000 proteins. Sci Data, 2020, 7(1): 263

[193] Singh R, Fatima E, Thakur L, Singh S, Ratan C, et al.. Advancements in CHO metabolomics: techniques, current state and evolving methodologies. Front Bioeng Biotechnol, 2024, 12: 1347138

[194] Sorourian S, Behzad Behbahani A, Rafiei Dehbidi G, Zare F, Farajnia S, et al.. Omics and CRISPR in CHO bioproduction: a state-of-the-art review. Biotechnol Bioprocess Eng, 2024, 29(3): 465-482

[195] Stolfa G, Smonskey MT, Boniface R, Hachmann AB, Gulde P, et al.. CHO-omics review: the impact of current and emerging technologies on Chinese hamster ovary based bioproduction. Biotechnol J, 2018, 13(3): e1700227

[196] Strasser L, Farrell A, Ho JTC, Scheffler K, Cook K, et al.. Proteomic profiling of IgG1 producing CHO cells using LC/LC-SPS-MS(3): the effects of bioprocessing conditions on productivity and product quality. Front Bioeng Biotechnol, 2021, 9: 569045

[197] Sumit M, Dolatshahi S, Chu AA, Cote K, Scarcelli JJ, et al.. Dissecting N-glycosylation dynamics in Chinese hamster ovary cells fed-batch cultures using time course omics analyses. iScience, 2019, 12: 102-120

[198] Svab Z, Braga L, Guarnaccia C, Labik I, Herzog J et al (2021) High throughput miRNA screening identifies miR-574-3p hyperproductive effect in CHO cells. Biomolecules 11(8). https://doi.org/10.3390/biom11081125

[199] Tanemura H, Kitamura R, Yamada Y, Hoshino M, Kakihara H, et al.. Comprehensive modeling of cell culture profile using Raman spectroscopy and machine learning. Sci Rep, 2023, 13(1): 21805

[200] Tasan I, Eres I, Wei C, Bryant EE, Brisan E, et al.. Identification of loci with high transgene expression in CHO cells. ACS Synth Biol, 2025, 14(6): 1948-1962

[201] Templeton N, Dean J, Reddy P, Young JD. Peak antibody production is associated with increased oxidative metabolism in an industrially relevant fed-batch CHO cell culture. Biotechnol Bioeng, 2013, 110(7): 2013-2024

[202] Thaisuchat H, Baumann M, Pontiller J, Hesse F, Ernst W. Identification of a novel temperature sensitive promoter in CHO cells. BMC Biotechnol, 2011, 11: 51

[203] Thalen NB, Barzadd MM, Lundqvist M, Rodhe J, Andersson M, et al.. Tuning of CHO secretional machinery improve activity of secreted therapeutic sulfatase 150-fold. Metab Eng, 2024, 81: 157-166

[204] Tihanyi B, Nyitray L. Recent advances in CHO cell line development for recombinant protein production. Drug Discov Today Technol, 2020, 38: 25-34

[205] Torres M, Elvin M, Betts Z, Place S, Gaffney C, et al.. Metabolic profiling of Chinese hamster ovary cell cultures at different working volumes and agitation speeds using spin tube reactors. Biotechnol Prog, 2021, 37(2): e3099

[206] Torres M, Betts Z, Scholey R, Elvin M, Place S, et al.. Long term culture promotes changes to growth, gene expression, and metabolism in CHO cells that are independent of production stability. Biotechnol Bioeng, 2023, 120(9): 2389-2402

[207] Tossolini I, Lopez-Diaz FJ, Kratje R, Prieto CC. Characterization of cellular states of CHO-K1 suspension cell culture through cell cycle and RNA-sequencing profiling. J Biotechnol, 2018, 286: 56-67

[208] Tossolini I, Gugliotta A, Lopez Diaz F, Kratje R, Prieto C. Screening of CHO-K1 endogenous promoters for expressing recombinant proteins in mammalian cell cultures. Plasmid, 2022, 119–120: 102620

[209] Tzani I, Herrmann N, Carillo S, Spargo CA, Hagan R, et al.. Tracing production instability in a clonally derived CHO cell line using single-cell transcriptomics. Biotechnol Bioeng, 2021, 118(5): 2016-2030

[210] Van Dyk DD, Misztal DR, Wilkins MR, Mackintosh JA, Poljak A, et al.. Identification of cellular changes associated with increased production of human growth hormone in a recombinant Chinese hamster ovary cell line. Proteomics, 2003, 3(2): 147-156

[211] Veith N, Ziehr H, MacLeod RA, Reamon-Buettner SM. Mechanisms underlying epigenetic and transcriptional heterogeneity in Chinese hamster ovary (CHO) cell lines. BMC Biotechnol, 2016, 16: 6

[212] Vito D, Smales CM. The long non-coding RNA transcriptome landscape in CHO cells under batch and fed-batch conditions. Biotechnol J, 2018, 13(10): e1800122

[213] Vito D, Eriksen JC, Skjodt C, Weilguny D, Rasmussen SK, et al.. Defining lncRNAs correlated with CHO cell growth and IgG productivity by RNA-Seq. iScience, 2020, 23(1): 100785

[214] Vodopivec M, Lah L, Narat M, Curk T. Metabolomic profiling of CHO fed-batch growth phases at 10, 100, and 1,000 L. Biotechnol Bioeng, 2019, 116(10): 2720-2729

[215] Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol, 2022, 40(12): 1722-1760

[216] Wang TY, Guo X. Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems. Appl Microbiol Biotechnol, 2020, 104(13): 5673-5688

[217] Wang Q, Yin B, Chung CY, Betenbaugh MJ. Glycoengineering of CHO cells to improve product quality. Methods Mol Biol, 2017, 1603: 25-44

[218] Wang XY, Du QJ, Zhang WL, Xu DH, Zhang X, et al.. Enhanced transgene expression by optimization of Poly A in transfected CHO cells. Front Bioeng Biotechnol, 2022, 10: 722722

[219] Wang W, Wang HT, Guo Y, Zhao Q, Lu JT, et al.. m6A modification profiles of the CHO cells with differential recombinant protein expression using MeRIP-seq/RNA-seq. Int J Biol Macromol, 2025, 310(Pt 4): 143429

[220] Wei YY, Naderi S, Meshram M, Budman H, Scharer JM, et al.. Proteomics analysis of Chinese hamster ovary cells undergoing apoptosis during prolonged cultivation. Cytotechnology, 2011, 63(6): 663-677

[221] Wei M, Mi CL, Jing CQ, Wang TY. Progress of transposon vector system for production of recombinant therapeutic proteins in mammalian cells. Front Bioeng Biotechnol, 2022, 10: 879222

[222] Weinguny M, Klanert G, Eisenhut P, Lee I, Timp W, et al.. Subcloning induces changes in the DNA-methylation pattern of outgrowing Chinese hamster ovary cell colonies. Biotechnol J, 2021, 16(6): e2000350

[223] Wippermann A, Rupp O, Brinkrolf K, Hoffrogge R, Noll T. The DNA methylation landscape of Chinese hamster ovary (CHO) DP-12 cells. J Biotechnol, 2015, 199: 38-46

[224] Wippermann A, Rupp O, Brinkrolf K, Hoffrogge R, Noll T. Integrative analysis of DNA methylation and gene expression in butyrate-treated CHO cells. J Biotechnol, 2017, 257: 150-161

[225] Wong DC, Wong KT, Lee YY, Morin PN, Heng CK, et al.. Transcriptional profiling of apoptotic pathways in batch and fed-batch CHO cell cultures. Biotechnol Bioeng, 2006, 94(2): 373-382

[226] Woo HJ, Kim J, Kim SM, Kim D, Moon JY, et al.. Context-dependent genomic locus effects on antibody production in recombinant Chinese hamster ovary cells generated through random integration. Comput Struct Biotechnol J, 2024, 23: 1654-1665

[227] Wu MYM, Rocamora F, Robinson CM, Shin S, Maurya S, et al.. Enhanced production of HCV E1E2 subunit vaccine candidates via protein-protein interaction identification in glycoengineered CHO cells. Biotechnol J, 2025, 20(9): e70112

[228] Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, et al.. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol, 2011, 29(8): 735-741

[229] Xu N, Ma C, Ou J, Sun WW, Zhou L, et al.. Comparative proteomic analysis of three Chinese hamster ovary (CHO) host cells. Biochem Eng J, 2017, 124: 122-129

[230] Xu WJ, Lin Y, Mi CL, Pang JY, Wang TY. Progress in fed-batch culture for recombinant protein production in CHO cells. Appl Microbiol Biotechnol, 2023, 107(4): 1063-1075

[231] Yang Y, Mariati, Chusainow J, Yap MG. DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines. J Biotechnol, 2010, 147(3–4): 180-185

[232] Yang Z, Wang S, Halim A, Schulz MA, Frodin M, et al.. Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat Biotechnol, 2015, 33(8): 842-844

[233] Yang W, Zhang J, Xiao Y, Li W, Wang T. Screening strategies for high-yield Chinese hamster ovary cell clones. Front Bioeng Biotechnol, 2022, 10: 858478

[234] Yang Y, Li Z, Li Q, Ma K, Lin Y, et al.. Increase recombinant antibody yields through optimizing vector design and production process in CHO cells. Appl Microbiol Biotechnol, 2022, 106(13–16): 4963-4975

[235] Yang YX, Li Q, Li WD, Wang TY, Feng HG. Factors and mechanisms affecting the secretion of recombinant protein in CHO cells. Curr Pharm Biotechnol, 2023, 24(3): 391-400

[236] Yao G, Aron K, Borys M, Li Z, Pendse G et al (2021) A metabolomics approach to increasing chinese hamster ovary (CHO) cell productivity. Metabolites 11(12). https://doi.org/10.3390/metabo11120823

[237] Yee JC, de Leon Gatti M, Philp RJ, Yap M, Hu WS. Genomic and proteomic exploration of CHO and hybridoma cells under sodium butyrate treatment. Biotechnol Bioeng, 2008, 99(5): 1186-1204

[238] Yee JC, Gerdtzen ZP, Hu WS. Comparative transcriptome analysis to unveil genes affecting recombinant protein productivity in mammalian cells. Biotechnol Bioeng, 2009, 102(1): 246-263

[239] Yin P, Li W, Zhao W, Guo M, Tong J. Multi-omics reveals impact of hypoxia on lactate metabolic switch and monoclonal antibody production in CHO fed-batch cultivation. Biotechnol J, 2025, 20(12): e70167

[240] Yusufi FNK, Lakshmanan M, Ho YS, Loo BLW, Ariyaratne P, et al.. Mammalian systems biotechnology reveals global cellular adaptations in a recombinant CHO cell line. Cell Syst, 2017, 4(5): 530-542e6

[241] Zeh N, Schmidt M, Schulz P, Fischer S. The new frontier in CHO cell line development: from random to targeted transgene integration technologies. Biotechnol Adv, 2024, 75: 108402

[242] Zhang A, Sun H, Xu H, Qiu S, Wang X. Cell metabolomics. OMICS, 2013, 17(10): 495-501

[243] Zhang HY, Fan ZL, Wang TY. Advances of glycometabolism engineering in Chinese hamster ovary cells. Front Bioeng Biotechnol, 2021, 9: 774175

[244] Zhang J, Wang L, Zhang X, Sun Q, Zhang J. Matrix attachment regions enhance transgene expression by manipulating position-dependent effects in stably transfected CHO-K1 cells. Biochem Cell Biol, 2024

[245] Zhang HJ, Zhao Q, Abiti J, Gao YP, Han MM, et al.. Effect of apoptosis and autophagy on recombinant protein expression in Chinese hamster ovary cells. Biotechnol J, 2025, 20(7): e70069

[246] Zhang JH, Wang C, Wu ZY, Mi CL, Han ZM, et al.. Engineering enhanced signal peptides: a high-throughput computational pipeline for optimizing therapeutic protein production in CHO cells. N Biotechnol, 2025, 90: 223-235

[247] Zhang X, Shen Y, Guo Z, Wang Y, Wang X, et al.. Cell engineering for increasing production of recombinant proteins in mammalian cells. BioDrugs, 2026, 40(1): 23-40

[248] Zhou G, Ewald J, Xia J. OmicsAnalyst: a comprehensive web-based platform for visual analytics of multi-omics data. Nucleic Acids Res, 2021, 49(W1): W476-W482

[249] Zhou G, Pang Z, Lu Y, Ewald J, Xia J. OmicsNet 2.0: a web-based platform for multi-omics integration and network visual analytics. Nucleic Acids Res, 2022, 50(W1): W527-W533

[250] Zhu Z, Chen X, Li W, Zhuang Y, Zhao Y, et al.. Understanding the effect of temperature downshift on CHO cell growth, antibody titer and product quality by intracellular metabolite profiling and in vivo monitoring of redox state. Biotechnol Prog, 2023, 39(4): e3352

Funding

National Natural Science Foundation of China(U23A20270)

Project of Technology Innovation Leading Talent in Central Plain(234200510003)

Science and Technology Research and Development Plan Joint Fund (Discipline) of Henan Province(252103810373)

Rights & permissions

The Author(s)